跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Estradiol/Progesterone
首页
药物
Estradiol/Progesterone
Estradiol/Progesterone
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
EP 3936133 A1
申请人: THERAPEUTICSMD INC
优先权: 2011
EP
US
WO
25 件公开
EP 4309646 A1
申请人: THERAPEUTICSMD INC
优先权: 2012
EP
US
17 件公开
US 10806740 B2
申请人: THERAPEUTICSMD INC
优先权: 2014
US
2 件公开
US 10206932 B2
申请人: THERAPEUTICSMD INC
优先权: 2015
US
2 件公开
CN 110290793 A
申请人: THERAPEUTICSMD INC
优先权: 2016
CN
Pharmaceutical formulation for contraception and hormone-replacement therapy
US 7589082 B2
申请人: SKENDI FINANCE LTD
优先权: 2004
CN
US
5 件公开
Trace elements
US 8377482 B2
申请人: WARBURTON TECHNOLOGY LTD
优先权: 2004
EP
US
5 件公开
Therapeutic Agent for Neuropathic Pain
US 2009197842 A1
申请人: JAPAN SCIENCE & TECH CORP
优先权: 2005
EP
US
WO
3 件公开
Compositions for preventing hormone induced adverse effects
US 7144586 B2
申请人: LYCORED NATURAL PROD IND LTD
优先权: 2000
US
3 件公开
COMPOSITION CONTAINING PROGESTIN, PHYTOESTROGEN AND ESTROGEN
US 2008167278 A1
申请人: RODRIGUEZ GUSTAVO C
优先权: 2007
US
3 件公开
Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient
US 10485808 B2
申请人: BAYER PHARMA AG
优先权: 2017
EP
US
2 件公开
ORAL PHARMACEUTICAL COMPOSITIONS OF PROGESTERONE AND ESTRADIOL
US 20250319101 A1
申请人: CHEMO RES S L
优先权: 2021
US
WO
2 件公开
COMPOSITION COMPRISING ESTRADIOL AND PROGESTERONE FOR USE FOR PREVENTING A MAJOR ADVERSE CARDIOVASCULAR EVENT IN A WOMAN
EP 4794703 A1
申请人: THERAMEX HQ UK LTD
优先权: 2023
EP
WO
2 件公开
Topical oestroprogestational compositions with a systemic effect
US 7030104 B2
申请人: THERAMEX
优先权: 2000
US
2 件公开
第 1 / 6 页
上一页
下一页
药物
反馈